Sepsis remains a significant cause of neonatal mortality and morbidity, especially in low-and
middle-income countries. Neonatal sepsis presents with nonspecific signs and symptoms …

This is a narrative review on the role of biomarkers in the diagnosis of neonatal sepsis. We
describe the difficulties to obtain standardized definitions in neonatal sepsis and discuss the …

Early-onset sepsis remains a common and serious problem for neonates, especially preterm
infants. Group B streptococcus (GBS) is the most common etiologic agent, while Escherichia …

Progress has been made in the reduction of morbidity and mortality from neonatal sepsis.
However, diagnosis continues to rely primarily on conventional microbiologic techniques …

Sepsis, a leading cause of morbidity and mortality throughout the world, is a clinical
syndrome with signs and symptoms relating to an infectious event and the consequent …

Clinical microbiology laboratories worldwide have historically relied on phenotypic methods
(ie, culture and biochemical tests) for detection, identification and characterization of …

In a prospective, multicenter study of 342 blood samples from 187 patients with systemic
inflammatory response syndrome, sepsis, or neutropenic fever, a new commercial PCR test …

Background New DNA-based microarray platforms enable rapid detection and species
identification of many pathogens, including bacteria. We assessed the sensitivity, specificity …

Bacterial sepsis in the neonate is a clinical syndrome characterized by systemic signs of
infection and accompanied by bacteremia in the first month of life. Meningitis in the neonate …

Sepsis is a major health problem in newborns and children. Early detection of pathogens
allows initiation of appropriate antimicrobial therapy that strongly correlates with positive …